期刊文献+

冠心病冠状动脉狭窄程度与ABO血型关系的初步研究 被引量:2

下载PDF
导出
摘要 目的:初步研究冠心病冠脉狭窄程度与ABO血型系统的关系。方法:对736例汉族冠脉造影患者的血型进行记录归类,并将ABO血型的分布情况与其冠脉造影结果进行对比分析。结果:对照组、单支病变组、双支病变组和多支病变组四组间ABO血型分布比较差异有统计学意义(P=0.03),并观察到冠脉病变累及血管数越多,非O型血的比例越高,B型血的检出比例也越高。各血型组的Gensini积分比较差异有统计学意义(P=0.037);A型组(28.75±10.23)分、B型(60.30±19.15)分、AB型(26.02±9.57)分,各组的Gensini积分均高于O型组(14.51±5.24)分,另外研究显示B型组的Gensini积分最高。结论:冠状动脉狭窄程度与ABO血型系统之间可能存在潜在关系,非O型血与冠脉狭窄相关,其中B型血与冠脉狭窄程度密切相关,值得进一步研究。
作者 吕云波
出处 《中外医学研究》 2012年第8期31-32,共2页 CHINESE AND FOREIGN MEDICAL RESEARCH
  • 相关文献

参考文献9

  • 1Tirado I,Mateo J,Sofia J M,et a1.The ABO blood group genotype and factorⅧlevels as independent risk factors for venous thromboembolism[J].Thromb Haemost,2005,93(3):468-474.
  • 2Schleef M,Strobel E,Dick A,et a1.Relationship between ABO and Secretor genotype with plasma levels of factorⅧand yon Willebrand factor in thrombosis patients and control individuals[J].Br J Haematol,2005,128(1):l00-107.
  • 3Carpeggiani C,Coceani M,Landi P,et a1.ABO blood group alleles:A risk factor for coronary artery disease.An angiographic study[J].Atherosclerosis,2010,211(2):461-466.
  • 4ACC/AHA Task Force.Guidelines for percutaneous translumina coronary angioplasty[J].J Am C oll Cardiol,2007,12(2):529-545.
  • 5Von Beckerath N,Koch W,Mehilli J.et a1.ABO locus Ol allele and risk of myocardial infarction[J].Blood Coagul Fibrinolysis,2004,15(1):61-67.
  • 6Minano A,Ord6nez A,Espafia F,et al.AB0blood group and risk of venous or arterial thrombosis in carriers of factor V Leiden or prothrombin G20210A polymorphisms[J].Haematologica,2008,93(5):729-734.
  • 7Sail I,Ozer O,Davutoglu V,et al.ABO blood group distribution and majorcardiovascular risk factors in patients with acute myocardial infarction[J].Blood Coagul Fibrinolysis,2008,19(3):231-234.
  • 8袁忠海,侯毅鞠,李艳,张慧,李中言,李欣,于东汇.冠心病患者vWF基因A1381T多态性分析[J].中国实验血液学杂志,2011,19(3):775-780. 被引量:7
  • 9Ketch T R,Turner S J,Sacrinty M T,et al.ABO blood types:Influence on infarct size,procedural characteristics and prognosis[J].Thromb Res,2008,123(2):200-205.

二级参考文献30

  • 1Lip GY, Blann AD. von Willebrand factor : a marker of endothelial dysfunction in vascular disorder? cardiovasc Res, 1997 ;34 (2) :255 - 265.
  • 2Meigs JB, Mittleman MA, Nathan DM, et al. Hyperinsulinemia hyperglycemia and impaired hemostasis: the frarningham offspring study. JAMA, 2000;283(2): 221 -283.
  • 3De lange M, de Geus EJ, Kluft C, et al. Genetic influences on fibrongen, tissue plasrainogen activator-antigen and yon Willebrand factor in male and females. Thromb Haemost, 2006 ;95 (3) :414 - 419.
  • 4Orstavik KH, Magnus P, Reiseuer H, et al. Factor Ⅷ and factor IX in a twin population: evidence for a major effect of ABO locus on factor Ⅷ level. Am J Hum Genet,1985 ; 37( 1 ) :89 - 101.
  • 5Mancuso DJ, Tuley EA, Westfield, et al. Structure of gene for human von Willebrand factor. J Biol Chem, 1989 ;264 (33) :19514 - 19527.
  • 6Bowen DJ, Collins PW. An amino acid polymorphism in von Willebrand factor correlates with increased susceptibility to proteolysis by ADAMTS13. Blood, 2004 ; 103 ( 3 ) :941 - 947.
  • 7Szanto T, Schlammadinger A, Staelens S, et al. The A/T1381 polymorphism in the A1 -domain of von Willebrand factor influences the affinity of von Willebrand factor for platelet glycoprotein lb alpha. Thromb Haemost, 2007 ;98 ( 1 ) : 178 - 185.
  • 8Klemm T, Mehnert AK, Siegemund A, et al. Impact of the Thr789Ala variant of the von Willebrand factor levels ,on ristocetin co-factor and collagen binding capacity and its association with coronary heart disease in patients with diabetes mellitus type 2. Exp Clin Endocrinol, 2005 ; 113 (10) :568 - 572.
  • 9Petrk O, Widimsky Jr J, Zelinka T, et al. Biochemical markers of endothelial dysfunction in patients with endocrine and essential hypertension. Physiol Res, 2006 ; 55 (6) :597 - 602.
  • 10Felmeden DC, Blann AD, Soencer CG, et al A comparison of flow-mediate Dilatation and von Wlllebrand factor as markers of endothelial cell function in health and in hypertension: relationship to cardiovascular risk and effects of treatment: a substudy of the Anglo- Scandinavian Cardiac Outcomes Trial. Blood Coagulation Fibrinolysis, 2003 ; 14 ( 5 ) :425 - 431.

共引文献6

同被引文献31

  • 1上海医科大学《实用内科学》编委.实用内科学[M].北京:人民卫生出版社,1993:1095-1104.
  • 2Carpeggiani C,Coceani M,Landi P, et al. ABO blood groualle- les: A risk factor for coronary artery disease. An angiographic study[J. Atherosclerosis,2010,211(2) =46D466.
  • 3Tirado I, Mateo J, Sofia JM, et al. The ABO blood group genotype an factor levels as independent risk factors for venous thrombo- embolismJ. Thromb Haemost, 2005,93 (3) .- 468-474.
  • 4Schleef M,Strobel E,Dick A, et al. Relationship between ABO an Secretor genotype with plasma levels of factor N and yon Willebrand factoin thrombosis patients and control individuals [J. Br J Haematol,2005,128(1) : 100-107.
  • 5李大鹏,靳丽,刘文清,等.鲁中南地区冠心病患者的ABO血型相关性研究[J].2008,36(3):425426.
  • 6yon Beckerath N, Koch W, Mehilli J. et al. ABO locus O1 al lele an risk of myocardial infarction[-J. Blood Coagul Fibri nolysis,2004,15 (1) :61-67.
  • 7Sail L,Ozer O,Davutoglu V,et al. ABO blood group distribu tion and majorcardiovascular risk factors in patients with a cute myocardia infarction E J 1. Blood Coagul Fibrinolysis 2008,19(3) 231-234.
  • 8Reilly MP, Li M, He J, et al. Identification of ADAMTS7 as a novel locus for coronary atherosclerosis and association of ABO with myocardial infarction in the presence of coronary atherosclerosis: two genome-wide association studies [J]. Lancet, 2011, 377(9763): 383-392.
  • 9Williams FMK, Carter AM, Hysi PG, et al. Ischemie stroke is asso- ciated with the ABO locus: The EuroCLOT study [J]. Ann Neurol, 2013, 73(1): 16-31.
  • 10Karakas M, Baumert J, Kleber ME, et al. A variant in the abo gene explains the variation in soluble E-Selectin levels-Results from dense genotyping in two independent populations [J]. PLoS One, 2012, 7(12): e51441.

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部